ALACHUA, FL--(Marketwire - May 13, 2008) - Oragenics, Inc. (AMEX: ONI) announced today that its Board of Directors approved the use of the Company's new name of ONI BioPharma Inc. The Company recently registered in the State of Florida to do business as "ONI BioPharma Inc." The Company will refer to itself as ONI BioPharma from this point forward and expects to seek to obtain shareholder approval to amend its articles of incorporation in order to formally change its name from Oragenics, Inc. to ONI BioPharma Inc. in connection with the next annual meeting of shareholders. The Company believes that the new name more accurately reflects the broad range of scientific platforms and products that the Company has under development through the efforts of its scientific team, headed by Dr. Jeffrey Hillman, our Chief Scientific Officer.
